Announced
Synopsis
Alcami, a provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, completed the acquisition of TriPharm Services, a drug manufacturer. Financial terms were not disclosed. "TriPharm represents a compelling opportunity for Alcami to capitalize on building an industry-leading position in attractive and growing end-markets. I look forward to working closely with the Alcami and TriPharm teams to ensure sustained growth in sterile fill-finish for Alcami," Harry Kraemer, Alcami Chairman.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.